3DHEALS Biomaterials 2024 đź—“

Category: Event,Webinar
Sep 05, 2024
Scheduled ical Google outlook Event Webinar

This annual virtual event dedicated to biomaterials and material science for 3D printing implants, medical devices, and biofabrication presents a unique and compelling opportunity for individuals across various disciplines to delve into the cutting-edge advancements shaping the future of healthcare. With the demand for innovative solutions in implantology and tissue engineering on the rise, this event serves as a pivotal platform for researchers, engineers, clinicians, entrepreneurs, and industry professionals to explore the latest breakthroughs and methodologies in biomaterials science. Attendees will have the chance to gain invaluable insights into the development of novel materials, fabrication techniques, and biofunctionalization strategies tailored for applications in 3D printing implants, medical devices, and biofabrication. From elucidating the fundamental properties of biomaterials to showcasing innovative approaches for enhancing biocompatibility, mechanical properties, and bioactivity of implants, this event offers a comprehensive overview of the current state-of-the-art in material science for medical applications. Moreover, the virtual format ensures accessibility to a global audience, facilitating networking opportunities and knowledge exchange among professionals from diverse backgrounds and regions.

Apply to speak or sponsor the event: info@3dheals.com

Subscribe here to receive event emails.


Rao Bezwada

Rao Bezwada

An accomplished scientist and entrepreneur, Rao S. Bezwada, Ph.D. established Bezwada Biomedical, an innovation-based and technology-driven research company, in 2003. The company is focused on developing a wide range of novel absorbable polymeric biomaterials to enhance quality of life by producing next generation bioabsorbable medical devices with therapeutic applications. Dr. Bezwada earned a doctorate in chemistry from the Stevens Institute of Technology in New Jersey and has over 40 years of research experience in the medical device industry, including 20 years of service at Ethicon, Inc. (a Johnson & Johnson Company). While at Ethicon, Dr. Bezwada’s research and development efforts led to the launch of a number of products, including Monocryl®, a new ultra-pliable synthetic absorbable monofilament suture. This product has represented worldwide sales of more than two (2) billion dollars since its launch in 1993 and current annual sales of over 100 million dollars. In recognition of this invention, along with its development, Johnson & Johnson, Inc. awarded Dr. Bezwada the prestigious Johnson Medal in 1996. Dr. Bezwada has been a prolific inventor and has been issued more than 135 U.S. patents on absorbable polyurethanes, absorbable amino acid polymers, absorbable polyester amides, absorbable polyoxaesters, and controlled release polymers. FDA-approved products such as MONTAGE® Putty, MONTAGE Fast Set Putty, Montage Flowable Putty, and PERMATAGE Putty, marketed by Abyrx for wound healing and bone applications, are based on Bezwada Biomedical’s absorbable polyurethane technology. Dr. Bezwada has also pioneered specialty bio-inks for 3D printing applications. In addition to his passion for science and technical accomplishments, Dr. Bezwada has also established a non-profit organization, Society for Basic Needs, in India. This organization has a mission aimed at improving the quality of life for those less fortunate by providing them with essential amenities and opportunities for health and education.

Mohammad Albanna, PhD

Dr. Albanna is the founder and CEO of Humabiologics, one of the only regenerative medicine companies focused on developing and commercializing human-derived biomaterials to researchers around the world for regenerative medicine applications. He holds a PhD in Biomedical Engineering, 2 master’s degrees in Materials Sciences and Electrical & Computer Engineering and completed a postdoctoral fellowship at Wake Forest Institute of Regenerative Medicine, where he served as the lead of the skin bioprinting group and is currently an adjunct assistant professor of Surgery at Atrium Health Wake Forest Baptist. Dr. Albanna authored several peer-reviewed papers, book chapters and is the inventor of several issued and patent-pending applications. Dr. Albanna has 15 years of industry experience, during which he has held several senior and executive leadership positions across several industries including medical devices, blood banking, and tissue banking. His work in regenerative medicine was recognized through several prestigious awards including 2013 Thomas Edison Gold Award in Innovation, 2018 Arizona Innovator of the year finalist, and 2021 Arizona Leader in Innovation Award.

Dimitria B. Camasao

Dimitria is the Senior Application Scientist at Rheolution, where she leads the development of applications for their analytical instruments in the life sciences sector. With over 10 years of research experience in hydrogels and soft polymers, Dimitria specializes in their mechanical properties. She believes that understanding the mechanical properties of biomaterials is crucial for the success of innovative treatments and medical devices, making thorough investigation essential. Dimitria holds a bachelor’s degree in Chemical Engineering from Universidade Estadual de Campinas (Brazil) and a Ph.D. in Materials Engineering from Université Laval (Canada).

Subscribe here to receive event emails.

Thanks to Our Sponsors: